Ongoing multi-state measles outbreaks fueled by under-vaccinated communities and imported cases from international travel continue to drive elevated case counts in 2026. As of May 7, the CDC reports 1,842 confirmed cases across 39 jurisdictions, with 93 percent outbreak-associated and roughly 72 percent occurring in children and adolescents. This trajectory already exceeds the pace of 2025’s full-year total of 2,288 cases—the highest since elimination in 2000—and reflects sustained transmission in pockets with MMR vaccination coverage below herd-immunity thresholds. Weekly CDC surveillance updates and summer-travel monitoring will provide key signals for whether incidence accelerates or declines before year-end resolution.
Tóm tắt AI thử nghiệm tham chiếu dữ liệu Polymarket. Đây không phải tư vấn giao dịch và không ảnh hưởng đến cách thị trường này được giải quyết. · Cập nhậtCác trường hợp mắc bệnh sởi ở Hoa Kỳ vào năm 2026?
Các trường hợp mắc bệnh sởi ở Hoa Kỳ vào năm 2026?
$7,669,891 KL.
$7,669,891 KL.
Dec 31, 2026
↑2k
99%
↑3k
62%
↑4k
28%
↑5k
14%
↑7,5k
14%
↑10k
10%
↑12,5k
5%
$7,669,891 KL.
$7,669,891 KL.
Dec 31, 2026
↑2k
$45,436 KL.
99%
↑3k
$50,414 KL.
62%
↑4k
$170,864 KL.
28%
↑5k
$215,382 KL.
14%
↑7,5k
$174,338 KL.
14%
↑10k
$6,493,848 KL.
10%
↑12,5k
$344,846 KL.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing multi-state measles outbreaks fueled by under-vaccinated communities and imported cases from international travel continue to drive elevated case counts in 2026. As of May 7, the CDC reports 1,842 confirmed cases across 39 jurisdictions, with 93 percent outbreak-associated and roughly 72 percent occurring in children and adolescents. This trajectory already exceeds the pace of 2025’s full-year total of 2,288 cases—the highest since elimination in 2000—and reflects sustained transmission in pockets with MMR vaccination coverage below herd-immunity thresholds. Weekly CDC surveillance updates and summer-travel monitoring will provide key signals for whether incidence accelerates or declines before year-end resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Thị trường mở: Feb 16, 2026, 11:51 AM ET
Khối lượng
$7,669,891Ngày kết thúc
Dec 31, 2026Thị trường mở
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing multi-state measles outbreaks fueled by under-vaccinated communities and imported cases from international travel continue to drive elevated case counts in 2026. As of May 7, the CDC reports 1,842 confirmed cases across 39 jurisdictions, with 93 percent outbreak-associated and roughly 72 percent occurring in children and adolescents. This trajectory already exceeds the pace of 2025’s full-year total of 2,288 cases—the highest since elimination in 2000—and reflects sustained transmission in pockets with MMR vaccination coverage below herd-immunity thresholds. Weekly CDC surveillance updates and summer-travel monitoring will provide key signals for whether incidence accelerates or declines before year-end resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Khối lượng
$7,669,891Ngày kết thúc
Dec 31, 2026Thị trường mở
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...Ongoing multi-state measles outbreaks fueled by under-vaccinated communities and imported cases from international travel continue to drive elevated case counts in 2026. As of May 7, the CDC reports 1,842 confirmed cases across 39 jurisdictions, with 93 percent outbreak-associated and roughly 72 percent occurring in children and adolescents. This trajectory already exceeds the pace of 2025’s full-year total of 2,288 cases—the highest since elimination in 2000—and reflects sustained transmission in pockets with MMR vaccination coverage below herd-immunity thresholds. Weekly CDC surveillance updates and summer-travel monitoring will provide key signals for whether incidence accelerates or declines before year-end resolution.
Tóm tắt AI thử nghiệm tham chiếu dữ liệu Polymarket. Đây không phải tư vấn giao dịch và không ảnh hưởng đến cách thị trường này được giải quyết. · Cập nhật
Cẩn thận với liên kết bên ngoài.
Cẩn thận với liên kết bên ngoài.
Câu hỏi thường gặp